BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Biocurate - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Biocurate
X-ORIGINAL-URL:https://www.biocurate.com
X-WR-CALDESC:Events for Biocurate
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231027
DTEND;VALUE=DATE:20231028
DTSTAMP:20260531T193525
CREATED:20231011T050023Z
LAST-MODIFIED:20231011T050023Z
UID:3225-1698364800-1698451199@www.biocurate.com
SUMMARY:Hit ID Symposium 2023
DESCRIPTION:The upcoming Hit ID Symposium will be held on 27 October 2023 at the Woodward Conference Centre\, in Melbourne\, Australia. This event will consist of scientific sessions\, interactive events and networking opportunities focussed on introducing delegates to the topic of hit identification within a small molecule drug discovery setting. \nThis is the first small molecule drug discovery symposium showcasing the hit identification infrastructure available within Melbourne’s Parkville precinct\, with a series of drug development success stories. The event provides a unique opportunity to be involved in a wide-reaching symposium that will focus on hit-finding screening campaigns in drug discovery\, delivered by experts actively working in the field from both within academia and industry. \nThe symposium will introduce researchers and clinicians to the topic of small molecule drug discovery and the support available to engage in such a program\, starting with the identification of a hit. Our program will guide participants through the different stages of small molecule drug discovery: how to do it\, how to fund it and how to protect it. This symposium will attract researchers who have an interest in drug discovery from the fields of biology and chemistry and groups involved in the translational and commercialisation space. \n\nBioCurate Associate Director of Medicinal Chemistry Discovery and Stakeholder Management Dr Tifelle Reisinger will be on the Funding Sources Panel discussion\nBioCurate Associate Director of Small Molecule Therapeutics Dr Belinda Huff will be attending\n\nThe program\, more information and registration details can be found here. \n
URL:https://www.biocurate.com/event/hit-id-symposium-2023/
LOCATION:Woodward Conference Centre\, Law Building\, 10th floor\, 106/185 Pelham St\, Carlton\, Victoria\, 3054\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/10/Untitled-design3.png
END:VEVENT
END:VCALENDAR